Transgene Biotek

• Sebi Bars Transgene Chief, 5 Officials From Capital Markets

  In a suspected case of round tripping through a web of cryptic deals running across India, Hong Kong and Switzerland, the Securities and Exchange Board of India (Sebi) has ordered a detailed probe into the alleged diversion of funds raised by pharmaceuticals company Transgene Biotek through issuance of global depository receipts (GDRs).

• TRANSGENE BIOTEK LTD. - Outcome of Board Meeting - Issue of GDRs

  Future & Option (F&O) total turnover stood at Rs 85523.22 crore on November 25, and the total numbers of contract traded on the day were 3646367.Of the total turnover, Index Futures contributed Rs 13112.20 crore, Stock Futures Rs 10997.96 crore and Index Options Rs 59185.02 crore while, the contribution of the Stock Options was of Rs 2228.0...

• TRANSGENE BIOTEK LTD. - Fixes Book Closure for AGM

  Transgene Biotek Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 28, 2011 to September 30, 2011 (both days inclusive) for the purpose of 21st Annual General Meeting (AGM) of the Company to be held on September 30, 2011.

• Transgene Biotek Ltd - Transgene Biotek to commence commercial production of another API - DHA

  Transgene Biotek Ltd has informed BSE that Transgene Biotek to commence commercial production of another API - DHA.

• Transgene's monoclonal antibody - uniquely effective against three cancers

  Transgene Biotek has announced that Therapeutic's monoclonal antibody (mAb) designed with usage of a specific peptide has demonstrated remarkable and exciting efficacy against three different cancers - colon cancer, Non-Hodgkin's Lymphoma and multiple myeloma.The company made this announcement during the trading hours today, 12 May 2010.

• Transgene Biotek net profit rises 77.78% in the March 2010 quarter

  Sales rise 12.62% to Rs 1.16 croreNet profit of Transgene Biotek rose 77.78% to Rs 0.16 crore in the quarter ended March 2010 as against Rs 0.09 crore during the previous quarter ended March 2009. Sales rose 12.62% to Rs 1.16 crore in the quarter ended March 2010 as against Rs 1.03 crore during the previous quarter ended March 2009.For the unaudite...

• Transgene expands the cancer drug pipeline

  A novel drug for Colon cancerTransgene Biotek has announced another novel drug to the existing cancer drug pipeline, a drug for treating Colon cancer. This drug for Colon cancer is based on our proprietary technology platform using a humanised monoclonal antibody (mAb).The company made this announcement during the trading hours today, 26 April 2010...

• Transgene Biotek jumps 8% in two days on R&D initiative

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Transgene Biotek jumps 8% in two days on R&D initiative

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Transgene Biotek jumps 8% in two days on R&D initiative

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Transgene Biotek develops new cancer drug against multiple myeloma

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Transgene Biotek in pink of health on filing for new patents

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Transgene Biotek files patents for AIDS vaccine & multiple sclerosis drug

  The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.

• Transgene files 2 patents for liver and breast cancer drugs

  Ajay Singh, director of SpiceJet, says a 10 per cent service tax imposed on domestic air travel in the Budget would mean an increase in air ticket prices by about Rs 350-400 given that the average economy fair is between Rs 3500-4000.

• Transgene Biotek jumps 25% in six days

  Ajay Singh, director of SpiceJet, says a 10 per cent service tax imposed on domestic air travel in the Budget would mean an increase in air ticket prices by about Rs 350-400 given that the average economy fair is between Rs 3500-4000.